Healthcare - Biotechnology - NASDAQ - US
$ 1.22
-3.17 %
$ 104 M
Market Cap
-0.71
P/E
Price Target
Average
907.03%
Revenue Forecast
Estimate
188.35%
EBIT
Estimate
21.94%
Net Income
Estimate
5.60%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Century Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for IPSC of $12.3 , with forecasts ranging from a low of $5 to a high of $25 .
IPSC Lowest Price Target
Wall Street Target
5 USD
309.84%
IPSC Average Price Target
Wall Street Target
12.3 USD
907.03%
IPSC Highest Price Target
Wall Street Target
25 USD
1949.18%
REVENUE FORECAST
Revenue Forecast Chart IPSC
EBIT FORECAST
EBIT Forecast Chart IPSC
NET INCOME FORECAST
Net Income Chart IPSC